Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8195 pt 1
|
pubmed:dateCreated |
1981-1-26
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0140-6736
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
2
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
651
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6107447-Adult,
pubmed-meshheading:6107447-Complement C1 Inactivator Proteins,
pubmed-meshheading:6107447-Complement C4,
pubmed-meshheading:6107447-Danazol,
pubmed-meshheading:6107447-Diagnosis, Differential,
pubmed-meshheading:6107447-Female,
pubmed-meshheading:6107447-Humans,
pubmed-meshheading:6107447-Lupus Erythematosus, Systemic,
pubmed-meshheading:6107447-Pregnadienes
|
pubmed:year |
1980
|
pubmed:articleTitle |
Reversal of lupus-erythematosus-like disease with danazol.
|
pubmed:publicationType |
Letter,
Case Reports
|